ERBB2 c.625_626inv ;(p.S209D)

Variant ID: 17-37866116-TC-GA

NM_004448.2(ERBB2):c.625_626inv;(p.S209D)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer.

Oncogene
Gong, Chun C; Tsoi, Ho H; Mok, Ka Chun KC; Cheung, Jenny J; Man, Ellen P S EPS; Fujino, Kazunari K; Wong, Ashely A; Lam, Eric W F EWF; Khoo, Ui-Soon US
Publication Date: 2020-04

Variant appearance in text: HER2: S209D
PubMed Link: 32066877
Variant Present in the following documents:
  • 41388_2020_Article_1210.pdf
View BVdb publication page



Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.

The Journal Of Biological Chemistry
Korneeva, Nadejda L NL; Song, Anren A; Gram, Hermann H; Edens, Mary Ann MA; Rhoads, Robert E RE
Publication Date: 2016-02-12

Variant appearance in text: HER2: S209D
PubMed Link: 26668315
Variant Present in the following documents:
  • Main text
View BVdb publication page